AC Immune SA
- Last sale
- Nov 12, 2026 · -5.31%
- Market cap
- $217.73M
- 101.74M shares
- Filings
- 313
FY 2025−86.9% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−26.1% FY25 yoy
- $217.73M
- —
- —
- —
- —
- —
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | CHF 3,573,000 | reported | |
| FY 2024 | 2024-12-31 | CHF 27,309,000 | reported | |
| FY 2023 | 2023-12-31 | CHF 14,801,000 | reported | |
| FY 2022 | 2022-12-31 | CHF 3,935,000 | reported | |
| FY 2021 | 2021-12-31 | CHF 0 | reported | |
| FY 2020 | 2020-12-31 | CHF 15,431,000 | reported | |
| FY 2019 | 2019-12-31 | CHF 110,456,000 revised | reported | |
| FY 2018 | 2018-12-31 | CHF 6,912,000 revised | reported | |
| FY 2017 | 2017-12-31 | CHF 20,255,000 | reported | |
| FY 2016 | 2016-12-31 | CHF 23,214,000 | reported | |
| FY 2015 | 2015-12-31 | CHF 39,090,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2022 | — | CHF 0.00 | CHF 0.00 | — | 83.62M sh | +0.2% | — |
| FY2021 | — | CHF 0.00 | CHF 0.00 | — | 83.48M sh | +16.0% | — |
| FY2020 | — | CHF 100.00K | CHF 100.00K | — | 71.94M sh | +0.1% | — |
| FY2019 | — | CHF 0.00 | CHF 0.00 | — | 71.86M sh | +6.4% | 0.0% |
| FY2018 | — | CHF 0.00 | CHF 0.00 | — | 67.56M sh | +17.8% | — |
Pharmaceutical preparations
AC Immune SA is the 245th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
IMRXImmuneering Corp———$237.0MCTNMContineum Therapeutics, Inc.———$226.4MGLSIGreenwich LifeSciences, Inc.———$222.7MINCRIntercure Ltd.———$218.7M
ACIUAC Immune SA (this company)———$217.7M
ZNTLZentalis Pharmaceuticals, Inc.$0.0100.0%—$217.2MSIGASiga Technologies Inc$94.6M31.8%24.6%$209.1MTRDAEntrada Therapeutics, Inc.$25.4M87.9%565.5%$203.2MELDNEledon Pharmaceuticals, Inc.———$199.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
AC Immune SA · CIK 1651625 · Engraved from SEC EDGAR